Market Overview

INMED PHARMS INC NEW by InMed Pharmaceuticals, Inc. (IMLFF)

5.64 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2021
Pre-Market
EPS:
REV:
-0.01
0



Q2 2021
Pre-Market
EPS:
REV:
-0.02
0



Q1 2021
Pre-Market
EPS:
REV:
-0.02
0



Q4 2020
Pre-Market
EPS:
REV:




Q3 2020
Pre-Market
EPS:
REV:


-0.01
0

Q2 2020
Pre-Market
EPS:
REV:
-0.02
0

-0.02
0

Q1 2020
Pre-Market
EPS:
REV:
-0.02
0

-0.02
0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!